[ Price : $8.95]
Amid data gaps and media questions about its level of transparency in setting up a hearing on petitions against its 2009 amalgam s...[ Price : $8.95]
CDRH says it completed 86% of the strategic priority tasks it wanted to accomplish in FY 2010.[ Price : $8.95]
Talecris Biotherapeutics plans a clinical trial evaluating the safety and the pharmacokinetic profile of two doses of Prolastin-C ...[ Price : $8.95]
A federal jury awards a man punitive and compensatory damages from Johnson & Johnson after finding that the company did not proper...[ Price : $8.95]
The Alliance for a Stronger FDA says a House-approved continuing resolution would treat FDA better than many other agencies by giv...[ Price : $8.95]
FDA issues a guidance for people who want to comment during advisory committee sessions.[ Price : $8.95]
Teva Pharmaceutical Industries says it could file an NDA late next year after reporting positive Phase 3 trials involving oral laq...[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period for Novartis Ilaris for the purpose of patent extension.